Hepatitis C treatment can be provided successfully at syringe programme sites


infohep.org, 18 April 2017

Administering direct-acting antiviral therapy for people who inject drugs at a syringe exchange site led to high sustained response rates in a pilot study in New York City. Expanding treatment for this population could reduce hepatitis C virus (HCV) transmission and ultimately help eliminate hepatitis C as a public health threat.

By J Pope

Your sidebar area is currently empty. Hurry up and add some widgets.